image
Healthcare - Biotechnology - NASDAQ - CA
$ 0.98
-2.97 %
$ 75.5 M
Market Cap
-3.77
P/E
BALANCE SHEET
38.8 M ASSETS
3.98%
11.3 M LIABILITIES
3.92%
27.6 M EQUITY
4.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Oncolytics Biotech Inc.
image
Current Assets 38.2 M
Cash & Short-Term Investments 34.9 M
Receivables 0
Other Current Assets 3.26 M
Non-Current Assets 647 K
Long-Term Investments 0
PP&E 647 K
Other Non-Current Assets -1
Current Liabilities 4.24 M
Accounts Payable 1.08 M
Short-Term Debt 133 K
Other Current Liabilities 3.02 M
Non-Current Liabilities 7.02 M
Long-Term Debt 290 K
Other Non-Current Liabilities 6.73 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999
ASSETS
Cash & Cash Equivalents 31.5 11.7 41.3 31.2 14.1 13.7 11.8 12.0 24.0 14.2 25.2 19.3 32.9 39.3 34.0 7.4 6.7 3.5 3.5 12.4 2.6 8.3 15.0 17.6 4.5
Short Term Investments 3.4 20.5 1.4 30.4 13.1 0 0 2.1 2.1 2.0 2.0 2.0 1.9 3.6 1.8 5.8 18.5 24.1 36.9 21.5 18.1 0 0 0 0
Receivables 0 0.5 0 89.7 K 0 51.6 K 4.8 54.4 K 0.3 0 0 45 K 55.4 K 0.3 64.8 K 86.3 K 80.1 K 84 K 47.4 K 47.8 K 0 48.5 K 95.3 K 0.1 19.7 K
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 23.9 K 0 0 0 0.5 0.3 0.2 0 24.2 K 0 0
Other Current Assets 3.2 1.7 2.8 2.4 2.7 0.7 1.2 0.3 0.5 0.3 0.4 0.3 0.7 0.3 0.5 0.2 0.3 0.6 0.5 0.3 0.2 77.2 K 2 39.3 K 15.3 K
Total Current Assets 38.2 35.7 44.9 33.7 18.9 14.5 17.8 14.4 26.9 16.7 27.7 21.7 35.6 43.5 36.3 13.5 25.6 28.3 41.0 34.2 21.0 8.4 15.1 17.8 4.6
PP&E 0.6 0.7 1.0 0.6 0.7 0.4 0.3 0.3 0.5 0.5 0.5 0.4 0.4 0.2 0.2 0.3 0.2 0.1 0.2 5.3 0.3 0.3 0.2 58.9 K 18.3 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 5.0 0 0 0 4.7 4.2 3.8 3.8 2.6
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 1 1.0 0 0 0 0 0 0 0 0 0 0 0 0.7 1 0 0 5.1 5.1 12 K 0.1 5.0 1 0 0
Other Assets 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 38.8 37.3 45.9 34.3 19.7 14.9 18.2 14.8 27.4 17.2 28.2 22.1 36.0 44.4 37.3 14.0 30.8 33.6 46.3 39.5 26.1 18.0 19.1 21.7 7.2
LIABILITIES
Accounts Payable 1.1 2.3 0.6 1.81 K 3.17 K 1.8 3.5 4.1 2.7 3.4 6.0 7.3 0 0 0 0 2.8 2.6 1.7 0.9 0.9 1.3 2.3 0.6 86.1 K
Short Term Debt 0.1 0.2 0.3 0.2 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 3.0 1.5 1.8 2.5 12.5 1.0 0.2 0 0 0 0 0 6.5 2.5 4.4 4.5 0 0 0 0 0 0 0 0 0
Total Current Liabilities 4.2 3.9 2.7 2.7 12.9 2.8 5.2 4.1 2.7 3.4 6.0 7.3 6.5 2.5 4.4 4.5 2.8 2.6 1.7 0.9 0.9 1.3 2.3 0.6 86.1 K
Long Term Debt 0.3 0.2 0.4 0.2 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Deferred Tax Income 0 (6.9) 6.73 K 6.73 K 6.73 K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 1.0 0
Other Liabilities 0 6.7 0 0 0 5.9 0 0 0 0 0 0 0 0 0 0 0.993 0 0 1 0 0 0 0 0
Total Liabilities 11.3 10.8 9.8 9.6 19.8 8.7 9.9 4.1 2.7 3.4 6.0 7.3 6.5 2.5 4.4 4.5 2.8 2.8 1.8 1.1 1.0 1.4 3.1 1.7 0.2
EQUITY
Common Stock 430.9 404.0 391.3 356.8 311.1 285.2 271.7 262.3 261.3 237.7 228.6 198.2 177.3 0 138.1 0 0 0 0 0 0 0 0 0 0
Retained Earnings (446.0) (418.3) (393.4) (367.1) (344.6) (311.5) (294.4) (278.8) (263.7) (250.0) (231.3) (207.8) (171.4) (138.8) (124.4) (102.6) (80.5) (65.0) (50.7) (38.0) (25.0) (16.5) (10.4) (4.2) (0.6)
Other Accumulative Comprehensive Income/Loss 0.5 0.7 0.4 0.4 0.5 0.6 0.4 0.6 0.8 0.3 79.7 K 57.1 K (0.1) (0.5) (0.5) (0.4) 5.3 4.2 4.4 9.7 5.3 2.7 2.5 2.5 2.5
Total Equity 27.6 26.5 36.1 24.8 (0.1) 6.2 8.3 10.7 24.7 13.8 22.2 14.8 29.5 41.9 32.8 9.5 28.0 30.8 44.5 38.4 25.0 16.6 16.0 19.9 6.9
Total Liabilities and Equity 38.8 37.3 45.9 34.3 19.7 14.9 18.2 14.8 27.4 17.2 28.2 22.1 36.0 44.4 37.3 14.0 30.8 33.6 46.3 39.5 26.1 18.0 19.1 21.7 7.2
SHARES OUTSTANDING
Common Shares Outstanding 67.6 58.0 53.5 40.3 22.1 16.0 13.9 12.6 11.9 9.2 8.8 8.0 7.5 6.6 5.2 4.4 4.3 3.8 3.4 3.0 2.5 2.2 1.9 1.7 0.6